Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124345162 | 12434516 | 2 | F | 20160623 | 20160603 | 20160711 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-040678 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160711 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124345162 | 12434516 | 1 | PS | ETOPOSIDE PHOSPHATE | ETOPOSIDE PHOSPHATE | 1 | Unknown | U | 20457 | POWDER FOR SOLUTION FOR INFUSION | |||||||||
124345162 | 12434516 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | U | 0 | ||||||||||
124345162 | 12434516 | 3 | SS | TAREXTUMAB | TAREXTUMAB | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124345162 | 12434516 | 1 | Small cell lung cancer |
124345162 | 12434516 | 2 | Small cell lung cancer |
124345162 | 12434516 | 3 | Small cell lung cancer |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124345162 | 12434516 | Anger | |
124345162 | 12434516 | Chest discomfort | |
124345162 | 12434516 | Diarrhoea | |
124345162 | 12434516 | Dyspnoea | |
124345162 | 12434516 | Rash | |
124345162 | 12434516 | Urticaria | |
124345162 | 12434516 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |